Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study

Autor: C.A. Uyl-de Groot, Z. Erjavec, E. (Vera) J. M. Mattijssen, Gerard Vreugdenhil, Kim M. Holtzer-Goor, Eduardus F. M. Posthuma, Simon Daenen, Peter C. Huijgens, P. W. Wijermans, W. G. Peters, H. Visser, M. R. Schaafsma, P. Joosten, S. Wittebol, M. H. J. Van Oers, K. G. van der Hem

Publikováno v: Quality of Life Research, 24(12), 2895-2906. Springer Netherlands
Quality of Life Research, 24(12), 2895-2906. SPRINGER
Holtzer-Goor, K M, Schaafsma, M R, Joosten, P, Posthuma, E F M, Wittebol, S, Huijgens, P C, Mattijssen, E J M, Vreugdenhil, G, Visser, H, Peters, W G, Erjavec, Z, Wijermans, P W, Daenen, S M G J, van der Hem, K G, van Oers, M H J & Uyl-de Groot, C A 2015, ' Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study ', Quality of Life Research, vol. 24, no. 12, pp. 2895-2906 . https://doi.org/10.1007/s11136-015-1039-y
Quality of Life Research, 24(12), 2895-2906. Springer, Cham
Quality of Life Research
Quality of life research, 24(12), 2895-2906. Springer Netherlands

Purpose To describe the health-related quality of life (HRQoL) of an unselected population of patients with chronic lymphocytic leukaemia (CLL) including untreated patients. Methods HRQoL was measured by the EORTC QLQ-C30 including the CLL16 module,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c7058cbb1613db4d1a60c05ddf2daf4
https://doi.org/10.1007/s11136-015-1039-y

Results of induction and consolidation treatment with intermediate and high-dose cytosine arabinoside and m-Amsa of patients with poor-risk acute myelogeneous leukaemia

Autor: W. G. Peters, Roelof Willemze, L. P. Colly

Publikováno v: European Journal of Haematology. 40:198-204

50 patients (aged 18-58 years) with acute myelogenous leukaemia after a preleukaemic phase (n = 14), acute myelogenous leukaemia that previously failed to respond to conventional chemotherapy (n = 9) or relapsed disease (n = 27) were given remission

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd8d5cd0f76084de5b1c9524f52c727e
https://doi.org/10.1111/j.1600-0609.1988.tb00824.x

The standardised mortality ratio: the proper quality indicator in acute leukaemia?

Autor: L, Saes, W G, Peters, R, Schaafsma, D J, van Spronsen, A W G, van der Velden, W F, van den Bosch, E, Meijer

Publikováno v: The Netherlands journal of medicine. 73(3)

The standardised mortality ratio (SMR) is a quality indicator used to measure quality of care in the Netherlands. It is subject to much criticism, which was the reason to study the value of the SMR as a quality indicator for the treatment of acute le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::115212f90c118a00ea8201b37d33dd7b
https://pubmed.ncbi.nlm.nih.gov/25852111

A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands

Autor: W. G. Peters, Simone Oerlemans, F. Mols, L.V. van de Poll-Franse, Marnix L.M. Lybeert, Djamila E. Issa, Wobbe P. Zijlstra, J.F.M. Pruijt, J.W.W. Coebergh

Publikováno v: Haematologica, 98(3), 479-486. Ferrata Storti Foundation
Oerlemans, S, Mols, F, Issa, D E, Pruijt, J H F M, Peters, W G, Lybeert, M, Zijlstra, W, Coebergh, J W W & van de Poll-Franse, L 2013, ' A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands ', Haematologica, vol. 98, no. 3, pp. 479-486 . https://doi.org/10.3324/haematol.2012.064907

The course of fatigue and quality of life in survivors of non-Hodgkin's lymphoma is unknown. The aims of this study were, therefore, to assess fatigue and quality of life in patients with non-Hodgkin's lymphoma following primary treatment, compare fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5198d5f3facb7d3270b5af576f818f17
https://research.vumc.nl/en/publications/a4878773-3c20-473d-8574-1168c9e7d41b

Compassionate use programme of irinotecan in colorectal cancer patients in The Netherlands

Autor: W W, ten Bokkel Huinink, C J, van Groeningen, E E, Voest, W G, Peters, H J, Keizer, J H, de Witte

Publikováno v: The Netherlands journal of medicine. 61(7)

Irinotecan is an effective treatment for metastatic colorectal cancer. However, its use may be associated with troublesome adverse effects such as delayed diarrhoea, acute cholinergic syndrome and neutropenic infection. The manufacturer decided to re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e536842121b51fc660ec9444b47502b2
https://pubmed.ncbi.nlm.nih.gov/14567522